Version 1
: Received: 8 October 2024 / Approved: 8 October 2024 / Online: 9 October 2024 (09:25:50 CEST)
How to cite:
Schuth, U. H.; Gill, K.; Bawamia, B.; Telyuk, P.; Austin, D.; Zaman, A. G. Role of Lipoprotein(a) Reduction in Cardiovascular Disease. Preprints2024, 2024100673. https://doi.org/10.20944/preprints202410.0673.v1
Schuth, U. H.; Gill, K.; Bawamia, B.; Telyuk, P.; Austin, D.; Zaman, A. G. Role of Lipoprotein(a) Reduction in Cardiovascular Disease. Preprints 2024, 2024100673. https://doi.org/10.20944/preprints202410.0673.v1
Schuth, U. H.; Gill, K.; Bawamia, B.; Telyuk, P.; Austin, D.; Zaman, A. G. Role of Lipoprotein(a) Reduction in Cardiovascular Disease. Preprints2024, 2024100673. https://doi.org/10.20944/preprints202410.0673.v1
APA Style
Schuth, U. H., Gill, K., Bawamia, B., Telyuk, P., Austin, D., & Zaman, A. G. (2024). Role of Lipoprotein(a) Reduction in Cardiovascular Disease. Preprints. https://doi.org/10.20944/preprints202410.0673.v1
Chicago/Turabian Style
Schuth, U. H., David Austin and Azfar G Zaman. 2024 "Role of Lipoprotein(a) Reduction in Cardiovascular Disease" Preprints. https://doi.org/10.20944/preprints202410.0673.v1
Abstract
Recent studies have shown that Lipoprotein(a) (Lp(a)) is an important risk factor for a plethora of different cardiovascular diseases. It has been proven that Lp(a) levels are genetically determined, and correlate with risk of cardiovascular disease, independent of lifestyle factors. As of yet, treatment options to reduce Lp(a) levels are limited, but new research into Lp(a) reduction yields promising results. This review delves into Lp(a) biochemistry, mechanism of effect, association between Lp(a) and cardiovascular diseases, and possible therapies to minimize cardiovascular disease.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
